Zoledronic Acid Injection IP
Zoledronic Acid Injection IP

Zoledronic Acid Injection IP

Price 300 INR/ Vial

MOQ : 1 Vial

Zoledronic Acid Injection IP Specification

  • Indication
  • Used for treatment of hypercalcemia of malignancy, bone metastases, and osteoporosis
  • Dosage Form
  • Injection
  • Salt Composition
  • Zoledronic Acid
  • Feature
  • Sterile, pyrogen free, for intravenous use only
  • Ingredients
  • Zoledronic Acid 4 mg
  • Application
  • Pharmaceutical/Medical
  • Ph Level
  • Approximately 6.07.0
  • Physical Color/Texture
  • Clear, colorless or almost colorless solution
  • Storage Instructions
  • Store below 30C. Do not freeze. Protect from light.
  • Shelf Life
  • 24 months
  • Administration Route
  • Intravenous infusion
  • Packaging Type
  • Single dose vial
  • Prescription Status
  • Prescription only
  • Compatibility
  • Should not be mixed with calcium-containing solutions
  • Strength
  • 4 mg/5 ml
  • Marketed By
  • Indian pharmaceutical company
 
 

About Zoledronic Acid Injection IP



Get elite care with Zoledronic Acid Injection IP (4 mg/5 ml), a famed therapy designed by an Indian pharmaceutical company. This unassailable, sterile, pyrogen-free solution comes in a clear, colorless or almost colorless single-dose vial, suitable for intravenous infusion only. Select this superb, prescription-only medication for effective management of hypercalcemia of malignancy, bone metastases, and osteoporosis. Its compatibility is ensured-do not mix with calcium-containing solutions. Store below 30C, protect from light, and never freeze. Shelf life is 24 months, making this injection reliable for distribution, export, and supply across India.

Distinctive Features & Premier Applications

Zoledronic Acid Injection IP delivers superb efficacy in reversing hypercalcemia of malignancy and reducing bone complications from osteoporosis and metastases. Its elite features include sterility, pyrogen-free formulation, and a precise pH range of approximately 6.0-7.0. Reserved strictly for intravenous use, this prescription-only, single-dose vial provides unassailable performance in pharmaceutical and medical settings, making it the select choice for healthcare practitioners seeking excellence in patient care.


Main Market Coverage & Seamless Handling

Primarily dispatched to the Indian domestic market, Zoledronic Acid Injection IP is also regularly handed over to international clients as part of our robust export network. As a trusted supplier, distributor, and trader, we facilitate smooth exchanges and prompt delivery for all pharmaceutical needs. Our sample policy is designed for transparency, often providing product samples before bulk exchange, ensuring clients receive exactly what they expect. Every order receives meticulous attention during storage and shipment.


FAQ's of Zoledronic Acid Injection IP:


Q: How is Zoledronic Acid Injection IP administered?

A: Zoledronic Acid Injection IP should be administered by intravenous infusion only, under the supervision of a qualified healthcare professional.

Q: What conditions does Zoledronic Acid Injection IP treat?

A: This injection is specifically indicated for the treatment of hypercalcemia associated with malignancy, bone metastases, and osteoporosis.

Q: When should Zoledronic Acid Injection IP not be used?

A: Zoledronic Acid Injection IP should not be mixed or administered with calcium-containing solutions and must be avoided in patients with hypersensitivity to zoledronic acid.

Q: Where should the solution be stored before use?

A: Store the injection below 30C, protect it from light, and do not freeze. Proper storage ensures the solution remains unassailable and effective for up to 24 months.

Q: What is the process to obtain the product for medical use?

A: Zoledronic Acid Injection IP is prescription only. A qualified healthcare provider can prescribe it, and it is available through authorized distributors, exporters, and suppliers across India and internationally.

Q: What are the extra benefits of using this specific Zoledronic Acid Injection?

A: The product is famed for its sterile, pyrogen-free formulation and single-dose convenience, enhancing both safety and ease of use during intravenous administration.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injection Category

Filgrastim Injection IP

Filgrastim Injection IP

Price 249 INR / Piece

Minimum Order Quantity : 1 Piece

Physical Color/Texture : Other , Clear, colorless solution

Application : Other, Parenteral use in hospitals and clinics for increasing white blood cell count

Dosage Form : Injection

Indication : Neutropenia, to promote neutrophil production in patients undergoing chemotherapy, bone marrow transplant, or HIV infection.

260 Mg Paclitaxel Injection IP

260 Mg Paclitaxel Injection IP

Price 800 INR / Vial

Minimum Order Quantity : 1 Vial

Physical Color/Texture : Other , Clear to pale yellow solution

Application : Other, Intravenous infusion

Dosage Form : Injection

Indication : Anticancer, ovarian cancer, breast cancer, nonsmall cell lung cancer

60 Ml Denosumab Solution Injection

60 Ml Denosumab Solution Injection

Price 6000 INR / Vial

Minimum Order Quantity : 1 Vial

Physical Color/Texture : Other , Clear to pale yellow, sterile solution

Application : Other, Subcutaneous administration by healthcare professionals only

Dosage Form : Parenteral (Injection)

Indication : Prevention of skeletalrelated events in patients with bone metastases from solid tumors, treatment of osteoporosis, and other bone loss indications as prescribed.

Doxorubicin Hydrochloride Injection IP

Doxorubicin Hydrochloride Injection IP

Price 975 INR / Vial

Minimum Order Quantity : 1 Vial

Physical Color/Texture : Other , Clear red solution

Application : Other, Antineoplastic agent for intravenous administration

Dosage Form : Injection

Indication : Used in the treatment of various cancers including breast cancer, bladder cancer, lymphoma, and leukemia



Back to top